|
Market Closed -
London S.E.
09:05:03 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.1600 GBX | 0.00% |
|
0.00% | -52.24% |
| 10/08 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 10/08 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
| Market Cap | 21.12L 28.62L 24.72L 23.23L 39.72L 27Cr 40.37L 2.72Cr 1.06Cr 14Cr 1.07Cr 1.05Cr 46Cr | P/E 2024 |
-0.53x | P/E 2025 | -0.62x |
|---|---|---|---|---|---|
| Enterprise Value | 13.22L 17.91L 15.47L 14.54L 24.86L 17Cr 25.27L 1.7Cr 66.61L 8.58Cr 67.26L 65.8L 29Cr | EV / Sales 2024 |
2,72,64,249x | EV / Sales 2025 | 5,41,21,446x |
| Free-Float |
91.05% | Yield 2024 * |
-
| Yield 2025 | - |
| Current month | +6.67% | ||
| 1 month | +10.34% | ||
| 3 months | -33.61% | ||
| 6 months | -49.21% | ||
| Current year | -52.24% |
| 1 week | 0.15 |  | 0.17 |
| 1 month | 0.14 | | 0.18 |
| Current year | 0.13 | | 0.48 |
| 1 year | 0.13 | | 0.85 |
| 3 years | 0.13 | | 15 |
| 5 years | 0.13 | | 65 |
| 10 years | 0.13 | | 1,436.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Eccleston
CEO | Chief Executive Officer | 55 | 12/08/2024 |
Gerald Desler
DFI | Director of Finance/CFO | 81 | - |
Michelle Barnard
CTO | Chief Tech/Sci/R&D Officer | - | 27/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Gerald Desler
BRD | Director/Board Member | 81 | 01/09/2006 |
| Chairman | 60 | 25/07/2024 | |
Mark Eccleston
BRD | Director/Board Member | 55 | 12/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/10/22 | Free | Director | 75,000 | 0.0832% | ||
| 18/10/22 | Free | Director | 75,000 | 0.0832% | ||
| 07/07/22 | Buy | Director | 1,00,000 | 0.1537% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -69.52% | -97.63% | 28.51L | |
| -1.90% | +11.59% | +62.29% | +102.60% | 7.16TCr | |
| -3.21% | -3.13% | +32.57% | +60.59% | 5.44TCr | |
| -2.07% | -5.31% | -2.83% | +456.66% | 2.76TCr | |
| -1.27% | +9.09% | +46.56% | +4.13% | 2.39TCr | |
| -0.01% | -0.64% | -17.42% | -13.37% | 2.31TCr | |
| +0.10% | +7.99% | +41.01% | -20.48% | 1.87TCr | |
| +3.81% | +16.28% | +270.78% | +488.06% | 1.86TCr | |
| -0.95% | +2.46% | +24.40% | +574.22% | 1.6TCr | |
| +1.27% | -5.38% | +32.99% | +137.84% | 1.25TCr | |
| Average | -0.41% | +0.91% | +42.08% | +169.26% | 2.66TCr | |
| Weighted average by Cap. | -1.19% | +0.29% | +50.59% | +160.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.05 0.07 0.06 0.05 0.09 6.45 0.1 0.64 0.25 3.23 0.25 0.25 10.73 | 0.03 0.04 0.04 0.03 0.06 4.06 0.06 0.4 0.16 2.04 0.16 0.16 6.76 |
| Net income | -19.16L -25.95L -22.42L -21.06L -36.02L -25Cr -36.61L -2.47Cr -96.5L -12Cr -97.44L -95.33L -41Cr | -22.32L -30.24L -26.12L -24.54L -41.97L -29Cr -42.66L -2.88Cr -1.12Cr -14Cr -1.14Cr -1.11Cr -48Cr |
| Net Debt | -15.44L -20.92L -18.07L -16.98L -29.03L -20Cr -29.51L -1.99Cr -77.78L -10Cr -78.54L -76.84L -33Cr | -8L -10.71L -9L -9L -14.86L -10Cr -15.1L -1.02Cr -39.81L -5.13Cr -40.19L -39.32L -17Cr |
Employees
11
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | GBX 0.1600 | 0.00% | 21,56,869 |
| 13/26/13 | GBX 0.1600 | 0.00% | 15,07,285 |
| 12/26/12 | GBX 0.1600 | 0.00% | 36,90,412 |
| 11/26/11 | GBX 0.1600 | 0.00% | 20,22,292 |
| 10/26/10 | GBX 0.1600 | 0.00% | 1,97,53,165 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VAL Stock
Select your edition
All financial news and data tailored to specific country editions
